Antifibrotic effect via the regulation of transcription factor Sp1 in lung fibrosis

Biochemical and Biophysical Research Communications

Volumn 363, Issue 2, 2007, Pages 368-374

  Kum, Yoon Seup ^a   Kim, Kyung Hyun ^a   Park, Tae In ^b   Suh, In Soo ^b   Oh, Hoon Kyu ^a   Cho, Chang Ho ^a   Park, Jae Bok ^a   Chang, Young Chae ^a   Park, Ji Hyun ^a   Lee, Kwang Gil ^c   Park, Kwan Kyu ^a  

^a Catholic University of Daegu   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c National Institute of Animal Science   (South Korea)

Author keywords

Decoy oligodeoxynucleotide; Lung fibrosis; TGF 1; Transcription factor Sp1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGENASE 3; FIBRONECTIN; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE TARGETING; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; MALE; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANIMALS; GENE TARGETING; GENE THERAPY; MALE; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDES; PULMONARY FIBROSIS; SP1 TRANSCRIPTION FACTOR; TREATMENT OUTCOME;

EID: 34848854517     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.08.176     Document Type: Article

References (19)

1. Verma S., and Slutsky A.S. Idiopathic pulmonary fibrosis-new insights. N. Engl. J. Med. 356 (2007) 1370-1372
2. Selman M., and Pardo A. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir. Res. 3 (2002) 3
3. Chae Y.M., Park K.K., Lee I.K., Kim J.K., Kim C.H., and Chang Y.C. Ring-Sp1 decoy oligonucleotide effectively suppresses extracellular matrix gene expression and fibrosis of rat kidney induced by unilateral ureteral obstruction. Gene Ther. 13 (2006) 430-439
4. Chu S., and Ferro T.J. Sp1: regulation of gene expression by phosphorylation. Gene 348 (2005) 1-11
5. Kim K.H., Kim H.C., Hwang M.Y., Oh H.K., Lee T.S., Chang Y.C., Song H.J., Won N.H., and Park K.K. The antifibrotic effect of TGF-beta1 siRNAs in murine model of liver cirrhosis. Biochem. Biophys. Res. Commun. 343 (2006) 1072-1078
6. Ashcroft T., Simpson J.M., and Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41 (1988) 467-470
7. Yang D., Lu H., and Erickson J.W. Evidence that processed small dsRNAs may mediate sequence-specific mRNA degradation during RNAi in Drosophila embryos. Curr. Biol. 10 (2000) 1191-1200
8. Sharp P.A. RNA interference-2001. Genes Dev. 15 (2001) 485-490
9. Yamashita J., Yoshimasa T., Arai H., Hiraoka J., Takaya K., Miyamoto Y., Ogawa Y., Itoh H., and Nakao K. Identification of cis-elements of the human endothelin-A receptor gene and inhibition of the gene expression by the decoy strategy. J. Biol. Chem. 273 (1998) 15993-15999
10. Ishibashi H., Nakagawa K., Onimaru M., Castellanous E.J., Kaneda Y., Nakashima Y., Shirasuna K., and Sueishi K. Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities. Cancer Res. 60 (2000) 6531-6536
11. Verrecchia F., Rossert J., and Mauviel A. Blocking sp1 transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: implications for the treatment of tissue fibrosis. J. Invest. Dermatol. 116 (2001) 755-763
12. Cook T., Gebelein B., and Urrutia R. Sp1 and its likes: biochemical and functional predictions for a growing family of zinc finger transcription factors. Ann. N. Y. Acad. Sci. 880 (1999) 94-102
13. Wang M., Zhao D., Spinetti G., Zhang J., Jiang L.Q., Pintus G., Monticone R., and Lakatta E.G. Matrix metalloproteinase 2 activation of transforming growth factor-beta1 (TGF-beta1) and TGF-beta1-type II receptor signaling within the aged arterial wall. Arterioscler Thromb. Vasc. Biol. 26 (2006) 1503-1509
14. Geiser A.G., Busam K.J., Kim S.J., Lafyatis R., O'Reilly M.A., Webbink R., Roberts A.B., and Sporn M.B. Regulation of the transforming growth factor-beta 1 and -beta 3 promoters by transcription factor Sp1. Gene 129 (1993) 223-228
15. Swiderski R.E., Dencoff J.E., Floerchinger C.S., Shapiro S.D., and Hunninghake G.W. Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 152 (1998) 821-828
16. Hay J., Shahzeidi S., and Laurent G. Mechanisms of bleomycin-induced lung damage. Arch. Toxicol. 65 (1991) 81-94
17. Willis B.C., Liebler J.M., Luby-Phelps K., Nicholson A.G., Crandall E.D., du Bois R.M., and Borok Z. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am. J. Pathol. 166 (2005) 1321-1332
18. Willis B.C., duBois R.M., and Borok Z. Epithelial origin of myofibroblasts during fibrosis in the lung. Proc. Am. Thorac. Soc. 3 (2006) 377-382
19. Lee J.M., Dedhar S., Kalluri R., and Thompson E.W. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 172 (2006) 973-981